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Abstract: Improving medication adherence is a critically important, but often enigmatic 
objective of patients, providers, and the overall health care system. Increasing medication 
adherence has the potential to reduce health care costs while improving care quality, patient 
satisfaction and health outcomes. While there are a number of papers that describe the benefits 
of medication adherence in terms of cost, safety, outcomes, or quality of life, there are limited 
reviews that consider how best to seamlessly integrate tools and processes directed at improv-
ing medication adherence. We will address processes for implementing medication adherence 
interventions with the goal of better informing providers and health care systems regarding the 
safe and effective use of medications.
Keywords: medication adherence, pharmacy, policy, health care systems, self-management, 
patient education
Improving medication adherence – an important 
unmet need and process of care
In the recently published National Community Pharmacists Association report on 
medication adherence, the cost of medication nonadherence in 2009 was estimated 
at $290 billion in the US.1,2 In addition to cost issues, and perhaps more compelling, 
are the potential clinical ramifications of medication nonadherence. Safety issues and 
suboptimal patient outcomes associated with poor medication adherence are estimated 
to impact 133  million Americans with at least one chronic disease.3 There is an increas-
ing business case for addressing medication nonadherence as payment and delivery 
system models evolve to place providers at risk for longitudinal patient outcomes and 
downstream costs (eg, bundled payments and accountable care organizations), provid-
ers’ interest in care coordination and durable treatment inventions expand.
Ongoing policy changes have resulted in a greater focus on individuals and 
medication adherence. The Health Information Technology for Economic and Clinical 
Health Act passed in 2009 as part of the American Recovery and Reinvestment Act, 
for example, authorizes an estimated $30 billion in incentives to eligible professionals 
and hospitals that adopt and meet federal standards for the meaningful use of certified 
electronic health record (EHR) technology.4 Meaningful use includes functions such 
as e-prescribing, reporting clinical quality measures, clinical decision support, and the 
electronic exchange of clinical messages between providers. The Health Information 
Technology for Economic and Clinical Health Act authorized another $2 billion to 
develop and support the nation’s health information technology (HIT) infrastructure 
and capacity to engage in the electronic exchange of health information. This included 
technical support for the adoption, maintenance, and meaningful use of EHR systems. 
Additionally, current Centers for Medicare and Medicaid Services Accountable Care 
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Organization performance standards include: enhanced 
patient experience (often associated with provider–patient 
communication); chronic illness disease control; and pro-
vision of preventive services. Last, increased attention on 
patient medication adherence has occurred because of the new 
Medicare Advantage Part D five-star quality rating system 
for medication adherence for 2014, which has recently been 
issued requiring all health care plans to have a four or better 
rating.5 Health plans earning four or five out of five avail-
able stars can receive bonus payments to be used to enhance 
benefits or lower future plan premiums to attract additional 
members. As part of Medicare Advantage Part D five-star 
quality-rating system, adherence to medications for hyperten-
sion, diabetes, and cholesterol are routinely examined as part 
of the Drug Pricing and Patient Safety Program.
The many facets of medication 
adherence – simplifying the equation
Many factors account for poor medication adherence 
ranging from patient socioeconomic status to provider 
training. For example, existing models of chronic disease 
 management6 and behavior change7 are informative, but our 
review takes a new approach. We combine the concepts of the 
health care system, patient and practice team from the Wagner 
Chronic Care Model,6 views from Michie et al7 such as regu-
lations and service provision, and perspectives from our own 
work to create this process plan for implementation. For the 
purpose of the review, we present a holistic plan to address 
medication adherence, focusing on three core components: 
1) patients; 2) providers; and 3) health care practices.
It is important to consider a few basic concepts. First, 
each patient is unique with specific clinical, educational and 
economic needs, and situational factors. Second, providers 
include physicians, nurses, pharmacists, or other allied health 
professionals who work collaboratively and contribute to 
care delivery. Last, for the purpose of this review, the terms 
“practice”, “health care system”, or the “health care plan” are 
interchangeable for this review, as the “system” must provide 
support to the providers and the patients in some meaningful 
way to address and improve the use of medicines as part of 
an overall treatment plan. These components form the criti-
cal relationship that drives engagement resulting in behavior 
change that will make a difference to improving medica-
tion adherence and patient outcomes (Figure 1). “ Better 
information, communication, and patient support have been 
shown in previous studies to increase patients’ engagement 
and involvement in their health care, their satisfaction.”1 
We begin with a case study and then discuss each component 
of the three core components (ie, patients, providers, and 
health care practices).
Case study: anticoagulation  
in stroke risk reduction – current 
and future options
In their recent study, Brown et al present a conceptual model 
for adherence to warfarin by combining insights from patient 
focus groups and a comprehensive literature review.8 As with 
any adherence challenge, this analysis looks at the multiple 
therapeutic and patient considerations to determine which 
influencers affect adherence to oral anticoagulation. This 
provides an overview of the multiple facets of improving 
adherence in anticoagulation. These are then replicated in our 
proposal for the emerging clinical coordination of patients 
with atrial fibrillation (AF); multiple influencers of medica-
tion use are brought together when a coordinated team-based 
approach is employed as outlined in our approach.
Based on the lessons learned, the process of adherence is 
impacted by: the patient’s disease knowledge and ongoing 
support from the health care team; the balance between short-
term avoidance of adverse events (eg, bleeding) or longer-term 
benefits (eg, reduction of stroke risk); developing a routine with 
therapy that may include external reminders; and patient self-
efficacy. So, indeed, the use of anticoagulation with warfarin in 
reducing the stroke risk associated with AF provides a compel-
ling story of medication use, misuse, and nonadherence.
It is well-appreciated that warfarin provides an impressive 
risk reduction for stroke inpatients with AF, particularly as the 
associated criteria of congestive heart failure, hypertension, 
age, diabetes,and prior stroke/transient ischemic attack – also 
known as the CHADS2 risk score- are included.9 The non- 
and underutilization of warfarin in patients with a diagnosis 
of AF is common and costly, according to a recent analysis 
by Casciano et al resulting in increased inpatient and total 
health care costs.10
It is generally accepted that only 50% of the patients who 
are eligible for warfarin are actually prescribed the drug for a 
Health care system 
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Figure 1 Simplified approach to improving medication adherence.





variety of reasons. Most prominently, however, it is the con-
sideration for the benefit of treatment versus the risk of major 
or minor bleeding events.11,12 There are often complex patient 
care considerations when using warfarin, such as bleeding, 
that necessitate monitoring. Anticoagulation clinics emerge 
as a way to address this problem. Patients develop consistent 
contact with a provider, are given comprehensive education 
about their illness and the treatment, and are expected to 
evaluate the care progress approximately once monthly. 
A challenge remains that only one-half of the patients pre-
scribed warfarin in the US have access to specific clinical 
providers, as described previously. While the aforementioned 
specialized clinics improve warfarin utilization, challenges 
remain in terms of safety and nonadherence that are associ-
ated with warfarin use. Access to specialized services is 
limited, and – as published in 2011 – adverse event data 
from a national data set reveals that warfarin was most often 
implicated in the emergency hospitalization of adverse drug 
events.19 Ultimately, improving anticoagulant adherence 
issues will avoid harm and improve outcomes in an often 
at-risk patient population.
What are the key lessons and practices that might improve 
adherence to warfarin as well as the newer approaches to 
anticoagulation? If we understand that improved adherence 
results in a more stable treatment response and reduced 
variability in overall patient response, then how should we 
proceed? The quality of care associated by structured sup-
port to patients who are prescribed warfarin is quantified by 
the percentage of patients who were kept in the therapeutic 
range. Clinical services provided by the specialty care 
pharmacist both identified the ability to improve care qual-
ity as measured by time in the therapeutic range and also 
reduced anticoagulation-related emergency room visits and 
hospitalizations.13
Coagulation clinics are opting out of the traditional clinic 
and moving to a service line, focusing on AF and preventive 
services, which not only include the management of antico-
agulation, but they also address common concurrent thera-
pies, such as antiarrhythmic monitoring as well as common 
comorbidities associated with AF, including hypertension, 
diabetes, and coronary disease. These service lines can be 
managed by advanced practice clinicians, such as nurses or 
pharmacists, collaborating with both specialists and primary 
care physician providers. Thus, as in diabetes care, a range 
of services can be provided or coordinated by well-trained 
midlevel practitioners and address often complex patient 
needs and behaviors, inclusive of proper medication usage 
and adherence.14 As suggested in Table 2, a series of clini-
cal issues or therapeutic challenges may be identified by a 
core/planning team who is responsible for identifying out-
puts. In this case, we also link educational support directed 
at the patient to – in part – address the therapeutic challenge 
and link inclusion into the medical record for verification 
across clinical services. Last, items of measurement need to 
be attached as part of focused quality improvement process 
in support of improved medication adherence.
Case study: HIT and lipid 
management
In a recently published analysis encompassing 34 trials with 
more than 84,000 enrolled patients, the impact of HIT to 
address quality gaps, including medication adherence, was 
evaluated in patients who required lipid management.15,16 HIT 
intervention processes (eg, screening, testing, drug initiation, 
titration, adherence, and/or referrals) were evaluated. Although 
a range of effects was found, more than one-third of the studies 
determined that an HIT intervention could impact outcomes. 
A core principle of this analysis was that the tools employed 
need to provide connectivity of the patient to the health care 
systems, as well as targeting providers and systems to improve 
lipid treatment, adherence, and quality. While any number 
of interventions may provide short-term value – particularly 
in practices and populations with low baseline adherence 
and low-density lipoprotein cholesterol control as a baseline 
consideration – long term effects may depend on longer-term 
support and follow-up as allocated in the study design. Ulti-
mately, intervention modalities that connect patients to the 
health care system may be more likely to provide practices 
with an unappreciated resource to improve lipid management, 
including adherence and low-density  lipoprotein cholesterol 
Table 1 Connectedness of patient, provider, and health care system
Patient Provider(s) Health care system
•	 Patient needs information and dialogue 
with providers to clarify preferences and 
assimilate learning from the provider 
encounter into a relevant plan for self-care 
(shared decision-making).
•	 Provider or team must provide information 
to patient in a sensitive and meaningful way, 
such that the patient is enabled to make 
shared decisions and is involved in care plan.
•	 System must enable access for patient to 
secure services and support clinical team 
to optimize patient care through education, 
compassion, and continuity of care.





control, resulting in a more patient-centric approach to disease 
management and treatment support.
Patient, provider, and health  
care system
The patient enters the health care system based on a wide 
range of possible circumstances – be it symptoms of a 
disease, preventive services, or often-unspecified concerns 
about their health or well-being. These encounters are also 
influenced by the nature of a practice environment, rang-
ing from a primary care orientation to specialized clinical 
services, where there may be not only a unique focus on 
clinical issues (eg, cardiovascular disease), but also access 
to a broader range of clinical providers, such as nurses, 
 pharmacists, cardiac rehabilitation professionals, and oth-
ers who engage with the patient in addition to the physi-
cian. Each of these types of providers may bring a unique 
skill-set and perspective. For example, in the US, clinical 
pharmacists may be specially trained experts in medication 
monitoring;17 in other countries, the role of pharmacists may 
be even greater. Consider the concept of the patient-centered 
medical home, where there is an increased level of support 
from HIT and decision support, continuity and coordination 
of care, and accountability by the health care system – all 
which emphasize a patient-focused and team-based approach 
to health care delivery.18 By adapting this model across 
the health care system, we can achieve  connected and 
 accountable care for patients that includes the appropriate 
use of medications (Table 1).
Transition to principles  
of medication adherence
Once the case to improve adherence has been made, what 
might a practice do to develop a medication adherence 
improvement plan? Given the many challenges within the 
delivery of health care, including time, patient-specific 
resources, and lack of adequate reimbursement, the ability 
to further incorporate medication management as a com-
ponent of care becomes even more challenging. Given that 
the problem of poor medication adherence is multifactorial, 
effective medication adherence programs need to adopt an 
approach that involves several proven strategies. Several 
evidence reviews have identified interventions effective in 
promoting both overall and condition-specific medication 
adherence.19–21 While no universal formula will improve 
medication adherence in all settings, several ingredients 
are essential for any well-designed medication adherence 
improvement intervention. These ingredients include: 
improving patients’ understanding of their treatments; 
providing counseling and accountability by the health care 
team; ensuring that there are tools and strategies to assist 
patient self-monitoring; and increasing access to affordable 
medications.21 There is a strong evidence base showing 
that the interventions that increase the patients’ knowledge 
Table 2 Process to evolve clinical services in AF
Identify therapeutic 
challenge
Establish team and 
deliverables
Patient education and 
support
Integration of IT Measurement
Underuse of standard 
anticoagulation with 
warfarin
Apply lessons learned 
from coordinated care 
model
modify content for patient 
education based on new 
service model
Adjust inputs in eHr 
beyond warfarin clinic 
support
Continue to identify 
appropriate patients 
who benefit from 
anticoagulation therapy 
based on risk criteria
emergence of newer 
anticoagulation
translate focus of AF 
management to newer 
treatment options
Determine specific 
messages on range  
of options for 
anticoagulation therapy
Update eHr and smart 
sets to address current 
patient needs
Compare results from 
clinical trials to compare 
translation of potential 
benefit and harm
Limited access of 
anticoagulation services
expand clinical services 
to include vascular 
disease prevention often 
associated with AF
expand access to include 
anticoagulation services, 
medication management,  
and vascular prevention
Broaden focus to include 
electrophysiology and 
general cardiology 
within a given practice 
environment
Determine value of AF 
and vascular prevention 
clinic across services 
within a cardiology 
practice
management of newer 
agents that may not 
require monitoring and 
monthly visits




Base patient visits on 
individual patient need and 
associated comorbidities
Set standards of care in 
AF patient population 




to address improved 
overall outcomes as 
well as patient safety 
and satisfaction
Abbreviations: EHR, electronic health record; AF, atrial fibrillation.





of medications22 and support behavioral change – coupled 
with medication management23 – are effective at improving 
medication adherence.
Approaching patient, practice, and 
provider – the adherence triad
Building upon the three components of the health care 
schema – the patient, the provider, and the practice – we 
now develop the concept of the adherence triad (Figure 2). 
The provider role is central to achieving buy-in and pro-
cess improvement, keeping treatment regimens simple and 
focused. Provider behavior change is reflected in the actions 
necessary to impact medication use. Training in the areas of 
health literacy, motivational interviewing, and information 
technology is useful for health care professionals to help edu-
cate and support their patients. The patient has a role to engage 
on different levels: with personal knowledge and support sys-
tems; with the provider before, during, and after the encounter; 
and the system to navigate and facilitate their own care success. 
The practice (system) has a role to encourage an environment 
where all the stakeholders understand the end game and provide 
simple seamless support mechanisms to improve patient care, 
outcomes, and satisfaction with the provision of care.
There are two keys to engagement for all members of 
the adherence triad. These are simplicity and fluidity. First 
and foremost, keep it simple. The responsibilities of each 
member of the adherence triad must be clearly articulated 
and understood. Ownership for each activity, the timing of 
it, and how it will be measured is vital to ensure that the 
patient care objectives are met. There must be fluid two-
way communication between all parties to ensure effective 
communication. The communication continuum should be 
nondisruptive and should seamlessly integrate into a given 
practice environment. The assessment of goals and objec-
tives is important to know whether all triad members are 
engaged and to make adjustments in real-time as needed. 
Each member of the triad should know what is expected 
and how best to evaluate success in meeting the long-term 
goals of success.
There are several key questions that must be considered 
when evaluating success. For example, is the evaluation of 
success comparable between the patient and their provider? 
How can the provider ensure the plan is understood and 
accepted by the patient? How can the patient, including his 
family and caregivers, be sure that the provider understood 
his priorities, challenges, and goals for treatment? How 
Adherence triad
WHO does WHAT, and HOW is it measured?
Supported by the practice 
environment, the provider(s)
take responsibility to outline 
a plan to support improved 
medication adherence.
Patient
Patient-focused education – 
about disease issues,
 treatment options, and tools
 that may assist the patient are 
reviewed. Set and manage
 expectations of the care plan.
Follow-up and keeping patient engagement 
are critical. Ensuring access to medication 
HIT support, use of websites, and patient 
empowerment strategies must be purposefully 
designed with the ability to assess over time.
Figure 2 Adherence triad.
Abbreviation: HIt, health information technology.





does the health care system maintain a process of ongoing 
quality improvement? There are many possible answers to 
the questions and no one-size-fits all solution. The tools and 
resources must be selected, based on the specific practice 
environment.
Tools and resources
The triad must organize tools and resources to facilitate medi-
cation adherence with a specific eye toward the unique needs 
of the patient. Patient education and methods for addressing 
modifiable patient-level factors that may influence adherence, 
such as health literacy, must be addressed. There are many 
patient educational resources – including medication instruc-
tion sheets, personalized medication calendars, streamlined 
pictorial bottle labels, and simple reminder systems – that 
can inform patients about their medication at a level aligned 
with their health literacy level.24,25 Technology provides many 
tools and resources that may facilitate improved adherence, 
including pill monitoring systems, mobile health technology, 
online resources, social media, and electronic health records, 
among others.26
Harnessing technology can also impact the frequency of 
patient–provider contact and ensure accountability. While 
there is no one universally established solution to foster 
proper medication adherence, HIT can inform numerous 
strategies to monitor adherence and improve rates, to inform 
patients’ self-management, health care service planning, and 
health policy decision making. Studies are increasingly dem-
onstrating that the use of IT can improve health outcomes and 
facilitate improvements in the quality and the coordination 
of care.19,20 Two common examples of HIT are e-prescribing, 
or the electronic generation of a prescription and its process 
for being filled at a pharmacy, and EHR systems.
When medication adherence tools and resources are used 
by the patient, understood by the provider, and endorsed 
by the practice, they form an important part of the plan to 
improve medication use. Through the adoption of HIT solu-
tions, adherence tools can also be used to ensure account-
ability of the triad both internally to its own members and 
externally to the broader health care delivery system. This 
can be used to inform a learning health care organization 
focused on continuous quality improvement.
Concluding remarks: plans  
to implement a medication 
adherence program
When developing and implementing a medication adherence 
improvement program, it is important that providers and 
health care systems consider three key questions. Have you 
identified medication adherence as a priority within your 
practice or organization? How do you want to affect medi-
cation use in your patient (population)? What are the avail-
able resources in terms of people, process, and investments 
to achieve your medication adherence goals? To examine 
these issues, providers and health care systems may form a 
working group to further evaluate the components of care 
within their specific practice environment. It is important to 
assess the available resources relative to the objectives in 
developing a plan; start small, perhaps focusing on specific 
patient population, disease area, or clinic space. Finally, 
be certain to incorporate a quality improvement approach 
at the onset of the program to measure, monitor, and adapt 
the program to meet potentially evolving patient care 
objectives. The Supplementary materials provide specific 
examples of web-based quality improvement agencies and 
resources, such as the Agency for Healthcare Quality and 
Research – Innovations Exchange and Pharmacy Quality 
Alliance (Figure S2).
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Review of adherence-related websites
Adult meducation: Improving medication 
Adherence in older Adults
Available at: http://www.adultmeducation.com/ 
The American Society on Aging (ASA) and the American Soci-
ety of Consultant Pharmacists (ASCP) Foundation have col-
laborated on the development of Adult Meducation: Improving 
Medication Adherence in Older Adults, a web-based program 
(Figure S1) to educate ASA and ASCP members on important 
aspects of medication adherence in older adults. One goal of 
the program is to encourage ASA members to work together 
with ASCP member pharmacists to identify, resolve, and pre-
vent medication nonadherence in the older adults served by 
community-based service providers. This website contains:
•	 Information on factors that influence medication adher-
ence, barriers to adherence, and specific strategies to 
improve adherence
•	 Tools to identify older adults at risk for medication 
nonadherence
•	 Resources to improve medication adherence
•	 Materials to educate older adults about the importance 
of medication adherence
•	 Educational programs targeted at community-based 
service providers and health professionals
•	 Links to other useful web resources
•	 Materials on the website that can be copied or downloaded 
for use in educational or training programs
Agency for Healthcare Quality  
and research – Innovations exchange
Available at: http://innovations.ahrq.gov/index.aspx 
In addition to user tools and project descriptions on a wide 
range of clinical issues, the website (Figure S2) provides 
specific tools and research summaries in the area of medi-
cation adherence, which can be utilized by clinicians and 
researchers alike.
American College of Preventive medicine
Available at: http://www.acpm.org/ 
The American College of Preventive Medicine provides a 
website (Figure S3) directed at providers to educate about 
the complex challenges of medication adherence with an 
additional summary of resources and tools, which may be 
incorporated into the practice environment.
Script your Future
Available at: http://www.scriptyourfuture.org/ 
The Script Your Future campaign is a national public educa-
tion campaign developed to raise awareness among patients, 
their family caregivers and health care professionals, about 
the importance of taking medications as directed. The 
Figure S1 Adult meducation: Improving medication Adherence in older Adults.
Figure S2 Agency for Healthcare Quality and research – Innovations exchange.
Figure S3 American College of Preventive medicine.





campaign, led by the National Consumers League, focuses 
on patients affected by three serious chronic conditions – 
diabetes, respiratory disease, and cardiovascular disease. 
Script Your Future educates patients about the consequences 
of poor adherence, encourages patients and health care 
professionals to better communicate about medication, and 
offers tools and resources to help improve adherence. The 
interactive Script Your Future website (Figure S4), offers 
tools for both patients and health care professionals, includ-
ing fact sheets on chronic conditions, charts to keep track 
of medications, videos, sample questions, text message 
alerts, and more.
Launched in May 2011, this unique three-year national 
campaign has targeted outreach efforts in: Baltimore, MD, 
USA; Birmingham, AL, USA; Cincinnati, OH, USA; Provi-
dence, RI, USA; Raleigh, NC, USA; and Sacramento, CA, 
USA. In addition to the website, the integrated campaign 
includes public service announcements, material dissemina-
tion, social media presence, health professions, and student 
out-reach activities. Script Your Future is supported by a 
coalition of more than 130 public and private partners.
national Council on Patient  
Information and education
Available at: http://www.talkaboutrx.org/ 
Founded in 1982, the National Council on Patient Informa-
tion and Education (NCPIE), located in Rockville, MD, 
USA, is a nonprofit multistakeholder coalition working to 
stimulate and improve the communication of information 
on the appropriate use of medicines to consumers and health 
care professionals. NCPIE, since its beginning, has strongly 
advocated for the medicine education team – considering the 
patient the key player. NCPIE develops and provides valu-
able patient education programs and educational resources 
promoting the latest advances in communication research 
and practice. NCPIE’s public-facing websites (Figure S5) 
include: talkaboutrx.org; bemedicinesmart.org; bemedwise.
org; mustforseniors.org; and recoveryopensdoors.org
NCPIE works to address critical medicine safe use 
issues like adherence improvement, prescription drug abuse 
prevention, treatment and recovery, medication error reduc-
tion, quality improvements in health care provider–patient 
medicine communication, and safe storage and disposal of 
medicines.
With mounting evidence that poor medicine adherence 
will increase dramatically with the projected rise in age-
related chronic illnesses, NCPIE released a nationwide call to 
action – the Accelerating Progress in Prescription Medicine 
Adherence: The Adherence Action Agenda (October 2013) – 
that places a spotlight on the pervasive and costly problem of 
poor medicine adherence, particularly among those age 65 
and older with multiple chronic conditions, who are at the 
greatest risk of medication errors, drug interactions, and 
costly disease complications.
north Carolina Program  
on Health Literacy
Available at: http://www.nchealthliteracy.org/ 
Health literacy is defined as the degree to which individuals 
have the capacity to obtain, process, and understand basic 
health information and services needed to make appropriate 
health decisions. The concept of health literacy differs from 
literacy itself. Health literacy requires basic reading skills, but 
it also requires the ability to understand oral communication, 
use numbers and math skills, understand how to navigate 
the health system on a basic level as well as the ability to 
communicate with health care providers and their staff. To 
that end, the University of North Carolina School of Public 
Health has provided an extensive list of tools and resources 
Figure S4 Script your Future.
Figure S5 national Council on Patient Information and education.
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to help clinicians better understand and implement good 
practices of health literacy (Figure S6).
Pharmacy Quality Alliance
Available at: http://www.pqaalliance.org
Established in 2006, the Pharmacy Quality Alliance is a 
501(c)(3) designated nonprofit alliance with more than 100 
member organizations (Figure S7). The Pharmacy Quality 
Alliance is a multistakeholder, consensus-based member-
ship organization that collaboratively promotes appropriate 
medication use and develops strategies for measuring and 
Figure S6 north Carolina Program on Health Literacy.
Figure S7 Pharmacy Quality Alliance.
reporting performance information related to medications. 
Their mission statement is clear:
To improve the quality of medication management and 
use across healthcare settings with the goal of improving 
patients’ health through a collaborative process to develop 
and implement performance measures and recognize 
examples of exceptional pharmacy quality.
national Patient Safety  
Foundation (nPSF)
Available at: http://www.npsf.org/about-us/ 
The NPSF’s vision is to create a world where patients and 
those who care for them are free from harm. A central voice 
for patient safety since 1997, NPSF partners with patients and 
families, the health care community, and key stakeholders 
to advance patient safety and health care workforce safety 
and disseminate strategies to prevent harm. NPSF is an inde-
pendent, not-for-profit 501(c)(3) organization. Among their 
resources is a unique clinician–patient interface tool called 
Ask Me 3 (Figure S8), which allows a quick effective engage-
ment with patients regarding medication adherence.
Figure S8 national Patient Safety Foundation.
